US Patent Issued to INSULET on Sept. 30 for "Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions" (Massachusetts, Wisconsin Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,431,229, issued on Sept. 30, was assigned to INSULET Corp. (Acton, Mass.).

"Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions" was invented by Joon Bok Lee (Acton, Mass.), Eric Benjamin (Cambridge, Mass.), Jason O'Connor (Acton, Mass.) and Yibin Zheng (Hartland, Wis.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The exemplary embodiments may modify a glucose cost component of the cost function of the control loop of an insulin delivery device to compensate for persistent positive low level glucose excursions relative to a target glucose level. The exemplary ...